SAGE - Sage Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 56.55B
Enterprise Value 34.84B
Trailing P/E N/A
Forward P/E 1-12.87
PEG Ratio (5 yr expected) 1-1.37
Price/Sales (ttm)72.83
Price/Book (mrq)6.62
Enterprise Value/Revenue 353.82
Enterprise Value/EBITDA 6-16.23

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-332.73%

Management Effectiveness

Return on Assets (ttm)-28.84%
Return on Equity (ttm)-47.78%

Income Statement

Revenue (ttm)90M
Revenue Per Share (ttm)2.02
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -298.54M
Net Income Avi to Common (ttm)-283.92M
Diluted EPS (ttm)-6.39
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.02B
Total Cash Per Share (mrq)21.78
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)19.07
Book Value Per Share (mrq)21.11

Cash Flow Statement

Operating Cash Flow (ttm)-217.79M
Levered Free Cash Flow (ttm)-117.47M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.14
52-Week Change 3-19.10%
S&P500 52-Week Change 3-6.95%
52 Week High 3195.97
52 Week Low 379.88
50-Day Moving Average 3108.36
200-Day Moving Average 3133.11

Share Statistics

Avg Vol (3 month) 3581.89k
Avg Vol (10 day) 3815.31k
Shares Outstanding 546.89M
Float 45.25M
% Held by Insiders 13.54%
% Held by Institutions 1105.16%
Shares Short (Dec 31, 2018) 43.52M
Short Ratio (Dec 31, 2018) 47.49
Short % of Float (Dec 31, 2018) 410.78%
Short % of Shares Outstanding (Dec 31, 2018) 47.51%
Shares Short (prior month Nov 30, 2018) 43.13M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A